[1]
“Psilocybin and Its Derivatives as a Promising Treatment for Treatment-Resistant Depression: A Review of Molecular Docking Studies and Mechanisms of Action at the Serotonin 2A Receptor”, pubs bcnf, vol. 2, no. 9, Dec. 2025, Accessed: Sep. 25, 2026. [Online]. Available: https://pubs.bcnf.ir/index.php/Articles/article/view/1178